Results 261 to 270 of about 152,669 (311)
Some of the next articles are maybe not open access.
Primary chemotherapy of epithelial ovarian carcinoma
Seminars in Surgical Oncology, 1994AbstractThis review provides a perspective on primary chemotherapeutic approaches in epithelial ovarian cancer. Chemotherapy is not recommended in grade 1 or 2 stage i‐a or b. In other early‐stage cases, postoperative melphalan or intraperitoneal radioactive phosphorus remain standard of care, even though these treatments have not been shown in a ...
G A, Omura, B S, Siller
openaire +2 more sources
Bone metastasis in epithelial ovarian carcinoma
International Journal of Gynecology & Obstetrics, 1996Two cases of bone metastasis in patients with epithelial ovarian carcinoma and a review of the literature are presented. Bone metastases detected antemortem are rare and herald a poor prognosis.
T V, Dinh +4 more
openaire +2 more sources
Salvage Chemotherapy for Epithelial Ovarian Carcinoma
Gynecologic Oncology, 1994Advanced epithelial ovarian cancer is a highly chemosensitive solid tumor with response rates of 70-80% to first-line chemotherapy, including a high proportion of complete responses. The majority of patients, however, eventually relapse and ultimately die of chemoresistant disease.
M C, Christian, E L, Trimble
openaire +2 more sources
Chemotherapy for advanced epithelial ovarian carcinoma
Best Practice & Research Clinical Obstetrics & Gynaecology, 2002Advanced epithelial ovarian cancer (AOC) is the most common clinical presentation of ovarian cancer. Virtually all patients will require some form of chemotherapy with curative or palliative intent. Prognostic factors, first- and second-line therapy, as well as experimental approaches for AOC are reviewed.
Nelson Gustavo Neder, Kalil +1 more
openaire +2 more sources
Cytogenetic studies of epithelial ovarian carcinoma
Cancer Genetics and Cytogenetics, 1993We performed cytogenetic studies of 36 human epithelial ovarian carcinomas using in situ culture and robotic harvest. We obtained analyzable metaphases of all 36 tumors (100%). One or more chromosomally abnormal clones were observed in 80% of tumors. Common clonal chromosome gains (each occurring in six or more cases) included +1, +2, +3, +6, +7, +9 ...
R B, Jenkins +7 more
openaire +2 more sources
Brain Metastases in Epithelial Ovarian Carcinoma
Gynecologic Oncology, 1995Central nervous system metastases from epithelial ovarian carcinoma are uncommon. A retrospective study was undertaken to see if there was a difference in brain metastases from ovarian cancer in our patient population as compared to the literature. A retrospective study of all patients diagnosed with brain metastases from epithelial ovarian carcinoma ...
J P, Geisler, H E, Geisler
openaire +2 more sources
Ifosfamide and Mesna in Epithelial Ovarian Carcinoma
Gynecologic Oncology, 1993Ifosfamide is a cyclophosphamide analogue synthesized in the 1960s with antineoplastic activity demonstrated in early broad-ranging phase I studies conducted in Germany in the 1970s. Because of significant urothelial toxicity, phase II studies in ovarian cancer in this country were delayed until the urinary epithelial protector mesna became available ...
openaire +2 more sources
Management of recurrent epithelial ovarian carcinoma
Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005AbstractDespite the standardisation of surgical techniques and significant progress in chemotherapeutics over the last 30 years, advanced epithelial ovarian cancer remains the most lethal gynaecological malignancy in the western world. Although the majority of women achieve a remission following primary therapy, most patients with advanced stage ...
openaire +5 more sources
The prognostic significance of thrombocytosis in epithelial ovarian carcinoma
Gynecologic Oncology, 2004The objective of this study was to determine the incidence of thrombocytosis in epithelial ovarian carcinoma and examine associations with clinico-pathologic features. Thrombocytosis (platelet counts >400 x 10(9)/l) has been identified as a poor prognostic factor in many cancers.
Andrew J, Li +5 more
openaire +2 more sources
Epithelial ovarian carcinoma of low malignant potential
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1996The aim of this study was to evaluate the interest of sonographic features, serum marker tumors and conservative treatment especially by laparoscopic approach of epithelial ovarian tumors of low malignant potential (or borderline tumors).Thirty-four patients with 40 epithelial ovarian tumors of low malignant potential treated at Bichat Claude Bernard ...
E, Darai +9 more
openaire +2 more sources